Modeling and Simulating Dynamics of Complete- and Poor-Response Chronic Hepatitis B Chinese Patients for Adefovir and Traditional Chinese Medicine Plus Adefovir Therapy

ChiCTR-TRC-11001263 study was the first large-scale double-blind randomized placebo-controlled traditional Chinese medicines (TCMs) and adefovir (ADV) antihepatitis B virus (HBV) infection trial in the world. A total of 560 hepatitis B e antigen- (HBeAg-) positive Chinese patients with chronical HBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Lequan, Chen, Xiao, Ye, Yongan, Zhang, Qun, Ru, Shuying, Li, Xiaoke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825269/
https://www.ncbi.nlm.nih.gov/pubmed/24282437
http://dx.doi.org/10.1155/2013/767290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825269/
https://www.ncbi.nlm.nih.gov/pubmed/24282437
http://dx.doi.org/10.1155/2013/767290

Ejemplares similares